The global “orange economy” generates billions in revenue. Trade in the creative industries can help protect freedom of expression and promote shared cultural experiences.
USTR’s annual Special 301 and Review of Notorious Markets for Counterfeiting and Piracy reports on the state of intellectual property rights around the world is a valuable tool for American companies.
How the Irish Music Rights Organization took on U.S. copyright law in the WTO – and won – yet your favorite pub is still allowed to play Irish music for you for free.
Special 301 rules direct the Office of the U.S. Trade Representative (USTR) to identify foreign countries that don’t do enough to protect intellectual property rights. Involvement from the private sector is also critical to prevent intellectual property theft.
The U.S. and China signed a trade deal on Jan 15. Attempting to rewire China’s economic system cannot be achieved in one pass – an agreement this ambitious would have to be built in phases. What does that mean for the future of trade deals?
The political winds seem to be blowing in favor of a Congressional vote on the U.S.-Mexico-Canada Free Trade Agreement (USMCA) yet this fall. But before they vote, some Members of Congress want to talk over a few issues with the Trump administration’s negotiators. One is intellectual property protections for the U.S. biopharmaceutical industry. As important as it is, the issue of data protection for biologic drugs is not well understood.
The popularity of American novels, textbooks, and scholarly works is driving efforts to translate and sell U.S.-published books in countries around the world. Digital publishing offers access to many more consumers beyond our borders. The main challenge to global expansion is the need to promote modern copyright regimes in the countries where publishers seek to sell more books
The National Inventors museum inducted fifteen more members into its Hall of Fame. Among those honored were Marvin Caruthers, Arogyaswami Paulraj, and Stan Honey. You may not have heard these names, but you’ve benefited from their inventions.
Despite the diffusion of drug production globally, a full three-quarters of spending on medicines in the United States is on products that are manufactured domestically, by both American and foreign companies.
President Trump just announced $50 billion worth of tariffs and other penalties on China for its theft of intellectual property, technology, and trade secrets. China will not change its behavior absent external pressure — pushing back against the constant drain from Chinese IP theft is long overdue.